HHS IG anti-kickback advisory opinions will be produced for a fee under interim final rule.
Executive Summary
HHS IG TO CHARGE FOR ANTI-KICKBACK ADVISORY OPINIONS under an interim final rule published in the Federal Register Feb. 18. The rule implements a requirement of the 1996 Kennedy/Kassebaum health insurance reform bill that the HHS Inspector General and the Department of Justice provide guidance upon request as to whether a particular arrangement violates federal anti-kickback laws under Medicare and Medicaid. Justice and the IG are proposing to bill for "actual costs incurred" in processing advisory opinion requests. The HHS Office of the Inspector General began accepting requests for legally binding advisory opinions Feb. 21.
You may also be interested in...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Shire Hopes To Sow Future Deals With $50M Venture Fund
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth